Guide to Application, Regulatory Requirements and Selection of Filter Integrity Testers for Sterile Pharmaceutical and Biopharmaceutical Processes

In the production of sterile pharmaceuticals and biopharmaceutical processes, a filter integrity tester is a dedicated non-destructive testing device for various filter cartridges, filter membranes and filtration systems. Unlike time-consuming microbial challenge tests, this instrument operates on purely physical detection principles without microbial incubation cycles. It can rapidly identify structural defects in filters such as cracks, oversized pore sizes, seal leaks and membrane damage. It serves as a core piece of equipment for compliance validation of sterile filtration processes and full-process quality control in manufacturing.

I. Regulatory Framework for Filter Integrity Testing

Major pharmacopoeias and regulatory authorities worldwide have incorporated filter integrity testing into mandatory control provisions for sterile drug production, with nuanced differences in requirements across jurisdictions:

China GMP (2010 Revised Annex 1 – Sterile Products)

It mandates integrity testing for sterile filters both before and after use. Accepted test methods include bubble point test, diffusion forward flow test and pressure hold test. Domestic regulations only require pre-use and post-use dual testing, without mandating Post-Sterilization Pre-Use Integrity Testing (PUPSIT). Enterprises may determine the timing of pre-use testing based on risk assessment.

US FDA Regulations and Industry Guidance

Although the term "integrity testing" is not explicitly stated in 21 CFR Part 211, integrity testing is defined as a core control measure to guarantee the effectiveness of sterile filtration within the compliance framework for sterile pharmaceutical manufacturing. The FDA guidance on aseptic processing of sterile drugs clarifies that integrity testing may be performed prior to filtration, while post-filtration testing is mandatory for routine monitoring. It highlights that post-filtration testing can detect leaks or damage occurring during the filtration process.

EU GMP Annex 1 (Revised August 2022)

Recognized globally as one of the most stringent standards for aseptic manufacturing, the revised version introduces and elaborates detailed PUPSIT requirements for sterile filters. It enforces integrity testing after filter sterilization and prior to production, alongside mandatory post-use re-testing. Comprehensive specifications are provided for real-time evaluation of test results, data integrity management, and alternative validation strategies for scenarios where in-line testing is unavailable.

Testing conducted before sterilization cannot substitute PUPSIT from a regulatory perspective. Pre-sterilization testing only acts as an auxiliary pre-validation step at the filter manufacturing stage and fails to cover membrane or seal damage caused by moist heat sterilization.

International Standards and Industry Technical Reports

ISO 13408-2 establishes standardized operational and technical criteria for aseptic processing of healthcare products. PDA Technical Report No. 26 (TR26) – Integrity Testing of Liquid Sterilizing Filters – is not a statutory regulation but a globally recognized industry reference document detailing the principles, applicable scenarios and result judgment logic of all integrity test methods.

Domestic Equipment Standards and Metrological Calibration Specifications

• Industry equipment standard: JB/T 20200-2021 Filter Integrity Tester, administered by the National Technical Committee for Pharmaceutical Equipment Standardization, effective February 1, 2022.

• Metrological calibration specification: JJF 2142-2024 Calibration Specification for Filter Integrity Testers, issued by the State Administration for Market Regulation on September 18, 2024, and effective March 18, 2025, applicable to the metrological calibration of such instruments.

II. Core Dimensions for Filter Integrity Tester Selection

A wide range of tester models are available on the market. Selection shall be comprehensively evaluated across four dimensions: compatibility with test methods, data integrity compliance, hardware performance parameters, and adaptability to cleanroom operating environments.

1. Compatibility with Test Methods

Each mainstream test method suits distinct application scenarios. Selection shall align with the filter types deployed at the facility, prioritizing precision for primary test methods rather than pursuing excessive functional integration:

• Diffusion Forward Flow: High sensitivity and strong correlation with bacterial retention efficiency, widely adopted for large-area hydrophilic sterile filters. Applicable to both large cartridges and small disc membranes, while bubble point testing offers simpler operation for small membrane formats.

• Water Intrusion Test: Eliminates the need for organic wetting agents such as isopropanol, delivering superior safety and ease of operation for hydrophobic filters and tank vent filters.

• Bubble Point Test: Fast and straightforward for rapid screening of small-area filter membranes; also viable for large-size cartridges with lower detection sensitivity compared to forward flow testing.

2. Data Integrity and Compliance Capabilities

Revised EU GMP Annex 1 imposes stricter software control requirements to support PUPSIT implementation. Instrument software must satisfy global data integrity standards:

• Hierarchical Access Control: Standard four-tier user accounts (Administrator, Engineer, Operator, Observer) with mandatory login for all testing operations.

• Audit Trail: Full logging of all critical operations and modifications with precise timestamps. Logs are write-protected and exportable locally or externally.

• Electronic Signature: Compliant with FDA 21 CFR Part 11 governing electronic records and electronic signatures.

• Data Storage & Export: Conventional models support storage of thousands of test records; a small number of high-end configurations can store over 300,000 datasets, with raw data export via USB drive, SD card, Ethernet and other channels.

3. Performance Precision and Key Parameters

Listed below are common industry parameter ranges, with premium high-end models capable of superior metrics:

• Test Ranges: Bubble point pressure 100–8000 mbar; forward flow 1–1000 mL/min; water intrusion 0.01–100 mL/min.

• Test Accuracy: Forward flow ±4%; bubble point ±50 mbar; water intrusion ±0.02 mL. High-end instruments achieve static pressure sensitivity up to ±0.5 mbar.

• Repeatability: General industry acceptance threshold ≤3%.

• Filter Compatibility: Covers disc membranes from Φ25 mm to Φ300 mm, standard pleated cartridges from 2.5 inch to 40 inch, multi-cartridge housings with 1 to 9 elements, and all types of air vent filters.

4. Application Scenarios and Mechanical Design

Equipment must meet specific requirements for cleanroom manufacturing environments:

• Ingress Protection: Front panels of mainstream testers reach IP65 rating for dust and splash water resistance.

• Human-Machine Interface: Color touchscreens with graphical guided operation workflows as standard configuration.

• Self-Test & Diagnostics: Built-in power-on self-check and hardware fault identification functions to avoid invalid tests caused by equipment malfunctions.

III. Regulatory Trends and Practical Considerations for PUPSIT

PUPSIT (Post-Sterilization Pre-Use Integrity Testing) has become a key focus of global regulatory inspections in recent years.

Regulators worldwide uniformly mandate post-use integrity testing, yet pre-use testing requirements differ significantly across jurisdictions. EU GMP enforces mandatory post-sterilization testing prior to use; China GMP only requires pre-use and post-use dual testing without specifying the post-sterilization timeline, allowing enterprises to formulate internal procedures based on risk assessment.

Core challenges of PUPSIT implementation: The wetting process must maintain full sterility downstream of the filter, and test gas must be fully purged from the downstream side. Standard practice employs sterile Water for Injection (WFI) to wet the upstream filter side, with a sterile barrier installed between the tester and filter piping.

Well-designed closed integrated SIP-compatible test piping completely eliminates additional contamination risks. Only poorly engineered open piping systems introduce potential contamination hazards. Facilities shall determine the test implementation approach based on production line layout, product characteristics and aseptic grade of the process.

IV. Guiding Principles for Handling Failed Integrity Tests

Current regulations do not specify a fixed allowable number of retests. Industry practice shall follow core guidance outlined in PDA TR26:

1. Every failed integrity test must be fully documented, triggering an immediate deviation investigation covering potential interferences including piping leakage, insufficient filter wetting, uncalibrated instruments, ambient temperature fluctuations and inherent filter damage.

2. Repeated retesting without documentation solely to achieve a passing result is prohibited. This constitutes a critical data integrity deficiency subject to major non-conformities during regulatory inspections.

3. Retesting may only commence after complete root cause analysis and implementation of corrective and preventive actions (CAPA). Filter failure shall not be judged by a fixed number of retest attempts.

V. Practical Selection Recommendations

1. Compile a complete inventory of all filter specifications in use, and verify full coverage of instrument test ranges and supported test methods item by item.

2. Request equipment suppliers to provide demo units for comparative testing within the actual cleanroom production environment, with frontline operators evaluating operational fluency and result stability.

3. Integrate supplier after-sales support into comprehensive evaluation criteria, including full 3Q validation documentation (IQ/OQ/PQ), annual metrological calibration, equipment maintenance and long-term software upgrade services.

With continuously tightening global regulatory standards for sterile pharmaceuticals and biologic products, filter integrity testing has evolved from a routine process check into a core compliance control point spanning the entire lifecycle: filter selection, process validation, routine manufacturing and deviation management. When procuring integrity testers, enterprises shall not rely solely on hardware parameters as the sole evaluation benchmark. Cross-regional regulatory compatibility, data integrity compliance, process adaptability and full-lifecycle technical support must be assessed in parallel. Standardized integrity testing workflows paired with regulation-compliant testing equipment reliably secure microbial retention performance of sterile filtration processes and mitigate product contamination risks. Meanwhile, robust compliance readiness streamlines responses to domestic and international regulatory audits, enabling dual control over manufacturing quality and regulatory adherence.